The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches
Open accessAbstract
BACKGROUND: Breast cancer is the most prevalent cancer among women worldwide and the fifth cause of death among all cancer patients. Breast cancer development is driven by genetic and epigenetic alterations, with the tumor microenvironment (TME) playing an essential role in disease progression and evolution through mechanisms like inflammation promotion. TNF-α is one of the essential pro-inflammatory cytokines found in the TME of breast cancer patients, being secreted both by stromal cells, mainly by tumor-associated macrophages, and by the cancer cells themselves. In this review, we explore the biological and clinical impact of TNF-α in all stages of breast cancer development. First of all, we explore the correlation between TNF-α expression levels at the tumor site or in plasma/serum of breast cancer patients and their respective clinical status and outcome. Secondly, we emphasize the role of TNF-α signaling in both estrogen-positive and -negative breast cancer cells. Thirdly, we underline TNF-α involvement in epithelial-to-mesenchymal transition (EMT) and metastasis of breast cancer cells, and we point out the contribution of TNF-α to the development of acquired drug resistance. CONCLUSIONS: Collectively, these data reveal a pro-tumorigenic role of TNF-α during breast cancer progression and metastasis. We systemize the knowledge regarding TNF-α-related therapies in breast cancer, and we explain how TNF-α may act as both a target and a drug in different breast cancer therapeutic approaches. By corroborating the known molecular effects of TNF-α signaling in breast cancer cells with the results from several preclinical and clinical trials, including TNF-α-related clinical observations, we conclude that the potential of TNF-α in breast cancer therapy promises to be of great interest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,580
DeNardo, D. G., Barreto, J. B., Andreu, P., Vasquez, L., Tawfik, D., Kolhatkar, N., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,353
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
Voduc, K. D., Cheang, M. C. U., Tyldesley, S., Gelmon, K., Nielsen, T. O., & Kennecke, H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9284 · Cited by 1,243
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., & Tamarkin, L. (2004) · Drug Delivery · doi:10.1080/10717540490433895 · Cited by 1,185
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085
TNF-α in promotion and progression of cancer
Balkwill, F. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9005-3 · Cited by 915
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 897
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 823
Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion
Wu, Y., Deng, J., Rychahou, P. G., Qiu, S., Evers, B. M., & Zhou, B. P. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.016 · Cited by 796
Ceramide in apoptosis: an overview and current perspectives
Pettus, B. J., Chalfant, C. E., & Hannun, Y. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00331-1 · Cited by 788
Goswami, S., Sahai, E., Wyckoff, J. B., Cammer, M., Cox, D., Pixley, F. J., Stanley, E. R., Segall, J. E., & Condeelis, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1853 · Cited by 738
Inhibition of JNK activation through NF-κB target genes
Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., & Lin, A. (2001) · Nature · doi:10.1038/35104568 · Cited by 721
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 710
New horizons in tumor microenvironment biology: challenges and opportunities
Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., & Sun, Y. (2015) · BMC Medicine · doi:10.1186/s12916-015-0278-7 · Cited by 704
DeNardo, D. G., & Coussens, L. M. (2007) · Breast Cancer Research · doi:10.1186/bcr1746 · Cited by 677
Stromal cells in tumor microenvironment and breast cancer
Mao, Y., Keller, E. T., Garfield, D. H., Shen, K., & Wang, J. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9415-3 · Cited by 671
Global trends in breast cancer incidence and mortality 1973–1997
Althuis, M. D., Dozier, J. M., Anderson, W. F., Devesa, S. S., & Brinton, L. A. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyh414 · Cited by 564
Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
Harrison, H., Farnie, G., Howell, S. J., Rock, R. E., Stylianou, S., Brennan, K. R., Bundred, N. J., & Clarke, R. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1681 · Cited by 543
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., & Joyce, J. A. (2011) · Genes & Development · doi:10.1101/gad.180331.111 · Cited by 541
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp, M. C., Floot, B. G., & Schellens, J. H. M. (1999) · PubMed · Cited by 487
Li, C.-W., Xia, W., Huo, L., Lim, S.-O., Wu, Y., Hsu, J. L., Chao, C.-H., Yamaguchi, H., Yang, N.-K., Ding, Q., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3123 · Cited by 467
TNF: A master switch for inflammation to cancer
Sethi, G. (2008) · Frontiers in Bioscience · doi:10.2741/3066 · Cited by 458
Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK
Hagemann, T., Wilson, J., Kulbe, H., Li, N. F., Leinster, D. A., Charles, K., Klemm, F., Pukrop, T., Binder, C., & Balkwill, F. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1197 · Cited by 434
Phase I study of recombinant tumor necrosis factor in cancer patients.
Blick, M. B., Sherwin, S. A., Rosenblum, M. G., & Gutterman, J. U. (1987) · PubMed · Cited by 426
The microenvironment in breast cancer progression: biology and implications for treatment
Place, A. E., Jin Huh, S., & Polyak, K. (2011) · Breast Cancer Research · doi:10.1186/bcr2912 · Cited by 413
HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway
Zhou, B. P., Hu, M. C.-T., Miller, S. A., Yu, Z., Xia, W., Lin, S.-Y., & Hung, M.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8027 · Cited by 371
Tsutsui, S., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., & Era, S. (2005) · Oncology Reports · doi:10.3892/or.14.2.425 · Cited by 366
Chang, S.-H., Liu, C. H., Conway, R., Han, D. K., Nithipatikom, K., Trifan, O. C., Lane, T. F., & Hla, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535911100 · Cited by 361
Priceman, S. J., Sung, J. L., Shaposhnik, Z., Burton, J. B., Torres-Collado, A. X., Moughon, D. L., Johnson, M., Lusis, A. J., Cohen, D. A., Iruela-Arispe, M. L., et al. (2010) · Blood · doi:10.1182/blood-2009-08-237412 · Cited by 356
Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., & Ben‐Baruch, A. (2002) · PubMed · Cited by 335
Monocyte/macrophage infiltration in tumors: modulators of angiogenesis
Dirkx, A. E. M., oude Egbrink, M. G. A., Wagstaff, J., & Griffioen, A. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905495 · Cited by 326
Luberto, C., Hassler, D. F., Signorelli, P., Okamoto, Y., Sawai, H., Boros, E., Hazen-Martin, D. J., Obeid, L. M., Hannun, Y. A., & Smith, G. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206747200 · Cited by 324
Roodhart, J. M. L., Daenen, L. G. M., Stigter, E. C. A., Prins, H.-J., Gerrits, J., Houthuijzen, J. M., Gerritsen, M. G., Schipper, H. S., Backer, M. J. G., van Amersfoort, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.010 · Cited by 305
Ben-Baruch, A. (2002) · Breast Cancer Research · doi:10.1186/bcr554 · Cited by 300
Soria, G., Ofri-Shahak, M., Haas, I., Yaal-Hahoshen, N., Leider-Trejo, L., Leibovich-Rivkin, T., Weitzenfeld, P., Meshel, T., Shabtai, E., Gutman, M., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-130 · Cited by 275
Asiedu, M. K., Ingle, J. N., Behrens, M. D., Radisky, D. C., & Knutson, K. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4554 · Cited by 270
Anti–Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis
Egberts, J.-H., Cloosters, V., Noack, A., Schniewind, B., Thon, L., Klose, S., Kettler, B., von Forstner, C., Kneitz, C., Tepel, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5704 · Cited by 259
IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients
Ma, Y., Ren, Y., Dai, Z.-J., Wu, C.-J., Ji, Y.-H., & Xu, J. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/62120 · Cited by 250
Tumor-associated macrophages: role in cancer development and therapeutic implications
Salmaninejad, A., Valilou, S. F., Soltani, A., Ahmadi, S., Abarghan, Y. J., Rosengren, R. J., & Sahebkar, A. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00453-z · Cited by 245
Epithelial-mesenchymal transition in breast cancer progression and metastasis
Wang, Y., & Zhou, B. P. (2011) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10226 · Cited by 235
Steinbach, D., Sell, W., Voigt, A., Hermann, J., Zintl, F., & Sauerbrey, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402541 · Cited by 226
Garg, M. (2013) · World Journal of Stem Cells · doi:10.4252/wjsc.v5.i4.188 · Cited by 209
Leek, R., Landers, R., Fox, S., Ng, F., Harris, A., & Lewis, C. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.373 · Cited by 207
Madhusudan, S., Foster, M., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., Talbot, D. C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0730 · Cited by 205
Tumour necrosis factor in man: Clinical and biological observations
Selby, P., Hobbs, S., Viner, C., Jackson, E., Jones, A., Newell, D., Calvert, A., McElwain, T., Fearon, K., & Humphreys, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.294 · Cited by 204
Inflammation and breast cancer
Constantinou, C., & Fentiman, I. S. (2013) · Breast Cancer Management · doi:10.2217/bmt.13.26 · Cited by 196
Storci, G., Sansone, P., Mari, S., D'Uva, G., Tavolari, S., Guarnieri, T., Taffurelli, M., Ceccarelli, C., Santini, D., Chieco, P., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22264 · Cited by 189
Yamamoto, M., Taguchi, Y., Ito-Kureha, T., Semba, K., Yamaguchi, N., & Inoue, J.-I. (2013) · Nature Communications · doi:10.1038/ncomms3299 · Cited by 189
Velasco-Velázquez, M. A., Homsi, N., De La Fuente, M., & Pestell, R. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.12.020 · Cited by 185
SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
Bhat-Nakshatri, P., Appaiah, H., Ballas, C., Pick-Franke, P., Goulet, R., Badve, S., Srour, E. F., & Nakshatri, H. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-411 · Cited by 182
Burow, M. E., Weldon, C. B., Tang, Y., Navar, G. L., Krajewski, S., Reed, J. C., Hammond, T. G., Clejan, S., & Beckman, B. S. (1998) · PubMed · Cited by 181
Systemic use of tumor necrosis factor alpha as an anticancer agent
Roberts, N. J., Zhou, S., Diaz, L. A., & Holdhoff, M. (2011) · Oncotarget · doi:10.18632/oncotarget.344 · Cited by 177
Seynhaeve, A. L. B., Hoving, S., Schipper, D., Vermeulen, C. E., aan de Wiel-Ambagtsheer, G., van Tiel, S. T., Eggermont, A. M. M., & ten Hagen, T. L. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1599 · Cited by 173
Baumgarten, S. C., & Frasor, J. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1302 · Cited by 172
Lin, E. Y., Li, J.-F., Bricard, G., Wang, W., Deng, Y., Sellers, R., Porcelli, S. A., & Pollard, J. W. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.10.003 · Cited by 168
Rivas, M. A., Carnevale, R. P., Proietti, C. J., Rosemblit, C., Beguelin, W., Salatino, M., Charreau, E. H., Frahm, I., Sapia, S., Brouckaert, P., et al. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.10.005 · Cited by 161
Intrinsic and Acquired Drug Resistance in Malignant Tumors
Lippert, T. H., Ruoff, H. J., & Volm, M. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296504 · Cited by 154
Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells
Timoshenko, A. V., Xu, G., Chakrabarti, S., Lala, P. K., & Chakraborty, C. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00269-6 · Cited by 153
Positive Cross-Talk between Estrogen Receptor and NF-κB in Breast Cancer
Frasor, J. M., Weaver, A., Pradhan, M., Dai, Y., Miller, L. D., Lin, C., & Stanculescu, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2608 · Cited by 148
The true face of JNK activation in apoptosis
Lin, A., & Dibling, B. C. (2002) · Aging Cell · doi:10.1046/j.1474-9728.2002.00014.x · Cited by 146
Tang, F., Tang, G., Xiang, J., Dai, Q., Rosner, M. R., & Lin, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8571-8579.2002 · Cited by 145
Katanov, C., Lerrer, S., Liubomirski, Y., Leider–Trejo, L., Meshel, T., Bar, J., Feniger-Barish, R., Kamer, I., Soria-Artzi, G., Kahani, H., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0080-7 · Cited by 145
Sacchi, A., Gasparri, A. M., Gallo‐Stampino, C., Toma, S., Curnis, F., & Corti, A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1147 · Cited by 144
Qiao, Y., He, H., Jonsson, P., Sinha, I., Zhao, C., & Dahlman‐Wright, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702571 · Cited by 140
Torroella‐Kouri, M., Silvera, R., Rodríguez, D., Caso, R., Shatry, A. M., Opiela, S. J., Ilkovitch, D., Schwendener, R. A., Iragavarapu‐Charyulu, V., Cardentey, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3427 · Cited by 134
Phase I study of recombinant human tumor necrosis factor
Kimura, K., Taguchi, T., Urushizaki, I., Ohno, R., Abe, O., FURUE, H., Hattori, T., Ichihashi, H., Inoguchi, K., Majima, H., et al. (1987) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00570490 · Cited by 133
Serum concentration of tumor necrosis factor in patients with breast cancer
Sheen‐Chen, S., Chen, W., Eng, H., & Chou, F. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005736712307 · Cited by 132
Zins, K., Abraham, D., Sioud, M., & Aharinejad, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2295 · Cited by 127
Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue
Miles, D. W., Happerfield, L. C., Naylor, M. S., Bobrow, L. G., Rubens, R. D., & Balkwwill, F. R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560603 · Cited by 124
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis
Eiró, N., González-Llorente, L., Martínez-Ordóñez, A., Fernández‐García, B., González, L. O., Cid, S., Domínguez, F., Pérez-Fernández, R., & Vizoso, F. J. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0371-y · Cited by 121
Tumor Necrosis Factor-α Promotes Malignant Pleural Effusion
Stathopoulos, G. T., Kollintza, A., Moschos, C., Psallidas, I., Sherrill, T. P., Pitsinos, E. N., Vassiliou, S., Karatza, M., Papiris, S. A., Graf, D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1064 · Cited by 120
Wolczyk, D., Zaremba-Czogalla, M., Hryniewicz-Jankowska, A., Tabola, R., Grabowski, K., Sikorski, A. F., & Augoff, K. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0280-x · Cited by 116
A phase I clinical trial of recombinant human tumor necrosis factor
Creagan, E. T., Kovach, J. S., Moertel, C. G., Frytak, S., & Kvols, L. K. (1988) · Cancer · doi:10.1002/1097-0142(19881215)62:12<2467::aid-cncr2820621202>3.0.co;2-5 · Cited by 116
Cai, X., Cao, C., Li, J., Chen, F., Zhang, S., Liu, B., Zhang, W., Zhang, X., & Ye, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16873 · Cited by 111
Bozcuk, H. S., Uslu, G., Samur, M., Yıldız, M., Özben, T., Özdoğan, M., Artaç, M., Altunbaş, H., Akan, I., & Savaş, B. (2004) · Cytokine · doi:10.1016/j.cyto.2004.04.002 · Cited by 106
Targeting Transmembrane TNF-α Suppresses Breast Cancer Growth
Yu, M., Zhou, G., Niu, L., Lin, G., Huang, J., Zhou, W., Gan, H., Wang, J., Jiang, X., Yin, B., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3946 · Cited by 97
Rubio, M. F., Werbajh, S., Cafferata, E. G. A., Quaglino, A., Coló, G. P., Nojek, I. M., Kordon, E. C., Nahmod, V. E., & Costas, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1209176 · Cited by 95
Rozen, F., Zhang, J., & Pollak, M. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.4.865 · Cited by 94
Pradhan, M., Bembinster, L. A., Baumgarten, S. C., & Frasor, J. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155309 · Cited by 92
Kim, Y. H., Ishii, G., Goto, K., Ota, S., Kubota, K., Murata, Y., Mishima, M., Saijo, N., Nishiwaki, Y., & Ochiai, A. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.10.008 · Cited by 87
Gregorc, V., Santoro, A., Bennicelli, E., Punt, C. J. A., Citterio, G., Timmer-Bonte, J. N. H., Cappio, F. C., Lambiase, A., Bordignon, C., & van Herpen, C. M. L. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605162 · Cited by 86
Nilendu, P., Sarode, S. C., Jahagirdar, D., Tandon, I., Patil, S. V., Sarode, G. S., Pal, J. K., & Sharma, N. K. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0388-2 · Cited by 83
Jupp, O. J., McFarlane, S. M., Anderson, H. M., LITTLEJOHN, A. F., MOHAMED, A. A. A., MacKAY, R. H., Vandenabeele, P., & MacEwan, D. J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590525 · Cited by 80
Coexpression of IL-6 and TNF-α: prognostic significance on breast cancer outcome
Tripsianis, G., PAPADOPOULOU, E., Anagnostopoulos, K. P., Botaitis, S., Katotomichelakis, M., Romanidis, Κ., Kontomanolis, E. N., Tentes, I. K., & Kortsaris, A. (2013) · Neoplasma · doi:10.4149/neo_2014_026 · Cited by 77
Wang, Y., Wang, X., Zhao, H., Liang, B., & Du, Q. (2012) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000049 · Cited by 77
TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells
Wu, X., Wu, M., Jiang, M., Zhi, Q., Bian, X., Xu, M., Gong, F.-R., Hou, J., Tao, M., Shou, L., et al. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0382-1 · Cited by 75
Jeoung, D., Tang, B., & Sonenberg, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18367 · Cited by 74
Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents
Brueggemeier, R. W., Richards, J. A., Joomprabutra, S., Bhat, A., & Whetstone, J. L. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00127-3 · Cited by 74
TNF inhibitor suppresses bone metastasis in a breast cancer cell line.
Hamaguchi, T., Wakabayashi, H., Matsumine, A., Sudo, A., & Uchida, A. (2011) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2011.03.051 · Cited by 72
Snyder, M., Huang, J., Huang, X., & Zhang, J. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591719 · Cited by 71
Hamed, E. A., Zakhary, M. M., & Maximous, D. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1176-4 · Cited by 66
Galmbacher, K., Heisig, M., Hotz, C., Wischhusen, J., Galmiche, A., Bergmann, B., Gentschev, I., Goebel, W., Rapp, U. R., & Fensterle, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009572 · Cited by 65
Frasor, J. M., Weaver, A., Pradhan, M., & Mehta, K. (2008) · Endocrinology · doi:10.1210/en.2008-0352 · Cited by 65
Koonce, N. A., Quick, C. M., Hardee, M. E., Jamshidi‐Parsian, A., Dent, J. A., Paciotti, G. F., Nedosekin, D. A., Dings, R. P. M., & Griffin, R. J. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.07.2275 · Cited by 65
Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?
Daniel, D., & Wilson, N. S. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783769346 · Cited by 59
Qiao, Y., Shiue, C.-N., Zhu, J., Zhuang, T., Jonsson, P., Wright, A. P. H., Zhao, C., & Dahlman‐Wright, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3158 · Cited by 58
Liu, F., You, X., Wang, Y., Liu, Q., Liu, Y., Zhang, S., Chen, L., Zhang, X., & Ye, L. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu021 · Cited by 55
Li, Y., Zhang, Z., Zhou, X., Li, L., Liu, Q., Wang, Z., Bai, X. F., Zhao, Y., Shi, H., Zhang, X., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.047 · Cited by 53
Tumour-associated macrophages in breast cancer and their prognostic correlations
Volodko, N., Reiner, A., Rudas, M., & Jakesz, R. (1998) · The Breast · doi:10.1016/s0960-9776(98)90065-0 · Cited by 53
Mosaffa, F., Lage, H., Afshari, J. T., & Behravan, J. (2009) · Inflammation Research · doi:10.1007/s00011-009-0034-6 · Cited by 50
Gene expression of the invasive phenotype of TNF-α-treated MCF-7 cells
Yin, Y., Chen, X., & Shu, Y. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.04.032 · Cited by 47
Effect of Tumour Necrosis Factor-Alpha on Estrogen Metabolic Pathways in Breast Cancer Cells
Kamel, M., Shouman, S. A., El-Merzebani, M. M., Kilic, G. S., Veenstra, T. D., SAEED, M. K., Wagih, M., Diaz‐Arrastia, C., Patel, D., & Salama, S. (2012) · Journal of Cancer · doi:10.7150/jca.4584 · Cited by 47
Li, T., Feng, Z., Jia, S., Wang, W., Du, Z., Chen, N., & Chen, Z. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1519-x · Cited by 43
Ji, X., Peng, Z., Li, X., Yan, Z., Yang, Y., Zheng, Q., & Liu, Y. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.031 · Cited by 43
The role of TNF-α in chordoma progression and inflammatory pathways
Güllüoğlu, Ş., Tüysüz, E. C., Şahin, M., Yaltırık, C. K., Kuşkucu, A., Özkan, F., Dalan, A. B., Şahin, F., Türe, U., & Bayrak, Ö. F. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00454-y · Cited by 41
Osmotic stress sensitizes naturally resistant cells to TNF-α-induced apoptosis
Franco, D. L., Nojek, I. M., Molinero, L. L., Coso, O. A., & Costas, M. A. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401074 · Cited by 36
Tripsianis, G., Papadopoulou, E. G., Romanidis, Κ., Katotomichelakis, M., Anagnostopoulos, K., Kontomanolis, E. N., Botaitis, S., Tentes, I. K., & Kortsaris, A. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6813 · Cited by 35
Donato, N. J., & Klostergaard, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.11.021 · Cited by 34
Estrogen Promotes Breast Cancer Cell Survival in an Inhibitor of Apoptosis (IAP)-dependent Manner
Stanculescu, A., Bembinster, L. A., Borgen, K. R., Bergamaschi, A., Wiley, E. L., & Frasor, J. M. (2010) · Hormones and Cancer · doi:10.1007/s12672-010-0018-6 · Cited by 34
Malekshah, O. M., Lage, H., Bahrami, A. R., Afshari, J. T., & Behravan, J. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.06.011 · Cited by 27
Rego, S. L., Helms, R. S., & Dréau, D. (2013) · Immunologic Research · doi:10.1007/s12026-013-8434-7 · Cited by 26
CXCL1 and CXCL2 link metastasis and chemoresistance
Feliciano, P. (2012) · Nature Genetics · doi:10.1038/ng.2379 · Cited by 17
Qiao, Y., He, H., Jonsson, P., Sinha, I., Zhao, C., & Dahlman‐Wright, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.702571 · Cited by 16
Cited by
Wang, S., Wang, J., Chen, Z., Luo, J., Guo, W., Sun, L., & Lin, L. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00522-z · Cited by 569
Lee, S.-H., Cho, S.-Y., Yoon, Y., Park, C., Sohn, J., Jeong, J.-J., Jeon, B.-N., Jang, M., An, C., Lee, S., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00831-6 · Cited by 325
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044002 · Cited by 263
Obesity and breast cancer: A case of inflamed adipose tissue
Kolb, R., & Zhang, W. (2020) · Cancers · doi:10.3390/cancers12061686 · Cited by 119
Metadata
- Authors
- Cruceriu, D., Baldasici, O., Balacescu, O., & Berindan-Neagoe, I.
- Venue
- Cellular Oncology
- Published
- 2020-01-03
- Volume
- 43
- Issue
- 1
- Pages
- 1-18
- ISSN
- 1570-5870 (ISSN-L)
- 2211-3428
- 2211-3436
- OpenAlex
- W2997398159
- Cited by
- 524
- References
- 131
- FWCI
- 17.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.